Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigs

Anesthesiology

Volumn 86, Issue 2, 1997, Pages 387-393

  Gries, André ^a   Böttiger, Bernd W ^b   Dörsam, Joachim ^b   Bauer, Harry ^b   Weimann, Jörg ^b   Bode, Christoph ^b   Martin, Elke ^b   Motsch, Johann ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Animal model: pig; Blood: platelet aggregation; Gases: inhaled nitric oxide; Lung: pulmonary embolism

Indexed keywords

ADENOSINE DIPHOSPHATE; MICROSPHERE; NITRIC OXIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; END TIDAL CARBON DIOXIDE TENSION; HEMATOCRIT; HEMODYNAMICS; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG EMBOLISM; MEAN ARTERIAL PRESSURE; MONITORING; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD PRESSURE; NITRIC OXIDE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PULMONARY EMBOLISM; SWINE;

EID: 0342601384     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199702000-00013     Document Type: Article

References (36)

1. McIntyre KM, Sasahara AA: The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971; 28:288-94
2. Huval WV, Mathieson MA, Stemp LI, Dunham BM, Jones AG, Shepro D, Hechtman HB: Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism. Ann Surg 1985; 197:220-5
3. Miczoch J, Tucker A, Weir EK, Reeves JT, Grover RF: Plateletmediated pulmonary hypertension and hypoxia during pulmonary microembolism: Reduction by platelet inhibition. Chest 1978; 74:648-53
4. Calvin JE: Acute right heart failure: Pathophysiology, recognition, and pharmacological management. J Cardiothorac Vasc Anesth 1991; 5:507-13
5. Utsunomiya T, Krausz MM, Levine L, Shepro D, Hechtman HB: Thromboxane mediation of cardiopulmonary effects of embolism. J Clin Invest 1982; 70:361-8
6. Todd MH, Forrest JB, Cragg DBJ: The effects of aspirin and methysergide, singly and in combination, on systemic haemodynamic responses to pulmonary embolism. Can Anaesth Soc J 1981; 28:373-80
7. Radomski MW, Palmer RMJ, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 305:1057-8
8. 2+ and on aggregation of human platelets. Eur J Pharmacol 1993; 244:37-47
9. Loscalzo J: Antiplatelet and antithrombotic effects of organic nitrates. Am J Cardiol 1992; 70:18B-22B
10. Roberts JD, Polaner DM, Lang P, Zapol WM: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:818-9
11. Rossaint R, Geriach H, Falke KJ; Inhalation of nitric oxide - a new approach in severe ARDS. Eur J Anaesthesiol 1994; 11:43-51
12. Sellden H, Winberg P, Gustaffson LE, Lundell B, Böök K, Frostell CG: Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2 kg Infant. ANESTHESIOLOGY 1993; 78:577-80
13. Böttiger BW, Motsch J, Dörsam J, Mieck U, Gries A, Weimann J, Martin E: Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets. Chest 1996; 110:1041-47
14. Pearl RG: Inhaled nitric oxide. The past, the present, and the future. ANESTESIOLOGY 1993; 78:413-6
15. Högman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G: Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 1994; 151:125-9
16. Högman M, Frostell C, Arnberg H, Hedenstierna G: Bleeding time prolongation and NO inhalation (letter), Lancet 1993; 341:1664-5
17. Samama CM, Diaby M, Fellahi JL, Mdhafar A, Eyraud D, Arock M, Guillosson JJ, Coriat P, RoubyJJ: Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. ANESTHESIOLOGY 1995; 83:56-65
18. 2 formation during application of inhaled nitrogen monoxide (NO), Anaesthesiol Intensivmed Notfallmed Schmerzther 1994; 29:157-62
19. Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927-9
20. Armstrong DJ, Miller SA: The role of platelets in the reflex tachypnoeic response to millary pulmonary embolism in anaesthetized rabbits. Exp Physiol 1990; 75:791-800
21. Böttiger BW, Bach A, Böhrer H, Martin E: Acute pulmonary embolism. Clinical, pathophystological, diagnostic, and therapeutic aspects. Anaesthesist 1993; 42:55-73
22. Ozier Y, Dubourg O, Farcot JC, Bazin M, Jardin F, Margairaz A: Circulatory failure in acute pulmonary embolism. Intensive Care Med 1984; 10:91-7
23. Beviglia L, Poggi A, Rossi C, McLane MA, Calabrese R, Scanziani E, Cook JJ, Niewiarowski S: Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins. Thromb Res 1993; 71:301-15
24. Hara H, Kitajima A, Shimada H, Tamao Y: Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models. Thromb Haemost 1991; 66:484-8
25. Gresele P, Corona C, Alberti P, Nenci GG: Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression. Thromb Haemost 1990; 64:80-6
26. Sheu JR, Huang TF: Ex-vivo and in-vivo antithrombotic effect of triflavin, an RGD-containing peptide. J Pharm Pharmacol 1994; 46:58-62
27. Moncada S, Palmer MJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharm Rev 1991; 43:108-42
28. Bassenge E: Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors. Eur Heart J 1991; 12(Suppl E):12-5
29. Malmros C, Blomquist S, Dahm P, Martensson L, Thörne J: Nitric oxide inhalation decreases pulmonary platelet and neutrophil sequestration during extracorporeal circulation in the pig. Crit Care Med 1996; 24:845-9
30. Radomski MW, Palmer RMJ, Moncada S: Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92:181-7
31. Harris SN, Rinder CS, Rinder HM, Tracey JB, Smith BE, Hines R: Nitroprusside inhibition of platelet function is transient and reversible by catecholamine priming. ANESTHESIOLOGY 1995; 83:1145-52
32. 1 in reducing pulmonary vascular resistance in an experimental model of acute lung injury. Crit Care Med 1990; 18:1129-33
33. Wanless RB, Anand IS, Poole-Wilson PA, Harris P: Haemodynamic and regional blood flow changes after acute pulmonary microembolism in conscious rabbits. Cardiovasc Res 1988; 22:31-6
34. Riegger GAJ, Hoferer P: A new experimental model for measurement of pulmonary arterial hemodynamic variables in conscious rats before and after pulmonary embolism and during general anesthesia. Cardiovasc Res 1990; 24:340-4
35. Schürmann M, Stiegler H, Riel KA, Schildberg FW: Lung embolism in a surgical patient sample: a retrospective study over 9 years. Chirurg 1992; 63:811-6
36. Hannon JP, Bossone CA, Wade CE: Normal physiological values for conscious pigs used in biomedical research. Lab Anim Sci 1990; 40:293-8